These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 25299893)

  • 41. More on Merkel-Cell Carcinoma.
    Blom A; Saiag P
    N Engl J Med; 2016 Feb; 374(5):494-5. PubMed ID: 26840149
    [No Abstract]   [Full Text] [Related]  

  • 42. First PI3k inhibitor launches into crowded hematology markets.
    Morrison C
    Nat Biotechnol; 2014 Oct; 32(10):963-4. PubMed ID: 25299893
    [No Abstract]   [Full Text] [Related]  

  • 43. [CAL-101,a novel agent of targeted therapy in hematological malignancies].
    Li CJ; Zhang Q; Zhang YZ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Apr; 22(2):530-3. PubMed ID: 24763037
    [TBL] [Abstract][Full Text] [Related]  

  • 44. CAL-101: a phosphatidylinositol-3-kinase p110-delta inhibitor for the treatment of lymphoid malignancies.
    Castillo JJ; Furman M; Winer ES
    Expert Opin Investig Drugs; 2012 Jan; 21(1):15-22. PubMed ID: 22112004
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Phosphoinositide 3-kinase α inhibitors: a patent review.
    Denny WA
    Expert Opin Ther Pat; 2013 Jul; 23(7):789-99. PubMed ID: 23488930
    [TBL] [Abstract][Full Text] [Related]  

  • 46. PI3Kδ inhibitors in cancer: rationale and serendipity merge in the clinic.
    Fruman DA; Rommel C
    Cancer Discov; 2011 Dec; 1(7):562-72. PubMed ID: 22586681
    [TBL] [Abstract][Full Text] [Related]  

  • 47. PI3Kδ and PI3Kγ as targets for autoimmune and inflammatory diseases.
    Cushing TD; Metz DP; Whittington DA; McGee LR
    J Med Chem; 2012 Oct; 55(20):8559-81. PubMed ID: 22924688
    [No Abstract]   [Full Text] [Related]  

  • 48.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 49.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 50.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 51.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 52.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 53.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 3.